Lessons to be learned from partnerships with families: a case study
β Scribed by Dr S Davidson; K Spowart
- Publisher
- Maney Publishing
- Year
- 2005
- Tongue
- English
- Weight
- 566 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1551-7853
- DOI
- 10.1002/edn.16
No coin nor oath required. For personal study only.
β¦ Synopsis
The following case study describes a therapeutic intervention with a seven-year-old child with diabetes and her family, at the centre of which was the partnership between two professionals, and between the family and the team. The work was informed by systemic models of family therapy and elements of cognitive behavioural therapy as well as best practice in working with families and young people with type 1 diabetes. The collaborative nature of multidisciplinary teams within paediatric diabetes, facilitates best outcomes for families of young children with type 1 diabetes and promotes continuity of care. The case study pays particular regard to the way in which practice is informed and evaluated by theory. Thus, relevant literature is signposted throughout the article, reflecting our use of documented strategies and issues that have been discussed further (and in greater depth) elsewhere.
π SIMILAR VOLUMES
Between October 1988 and December 1989, the district health management team (DHMT) of Same District, in Tanzania, tested out an action-based learning strategy to improve its management capability. The initiative was led by the Centre for Educational Development in Health, Arusha, which was seeking a
## Abstract The objective of this study was to analyse Swedish child sexual abuse cases from 1989 to 2004 characterised by the following: (1) conviction in first trial in a court of appeal; (2) the Supreme Court later accepted a petition for a new trial; and (3) acquittal in second trial in the sam
In the biotechnology area, the issue of comparability with an innovator product is complex. Ideally, a side-by-side comparison of physical properties would be part of the demonstration of comparability. However, biogeneric companies do not have access to the bulk drug substance from the innovator co
## Abstract ## Background Selfβmanagement programmes (SMPs) have been developed to help patients with chronic rheumatic diseases to manage their health problems. Patients' expectations prior to treatment are important determinants of outcomes, and should therefore be identified, to ensure that int